Title: Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication
Authors: Andrei, Graciela ×
Lisco, Andrea
Vanpouille, Christophe
Introini, Andrea
Balestra, Emanuela
van den Oord, Joost
Cihlar, Tomas
Perno, Carlo-Federico
Snoeck, Robert
Margolis, Leonid
Balzarini, Jan #
Issue Date: Oct-2011
Publisher: Cell Press
Series Title: Cell Host & Microbe vol:10 issue:4 pages:379-389
Abstract: The HIV reverse-transcriptase inhibitor, tenofovir, was recently formulated into a vaginal gel for use as a microbicide. In human trials, a 1% tenofovir gel inhibited HIV sexual transmission by 39% and, surprisingly, herpes simplex virus-2 (HSV-2) transmission by 51%. We demonstrate that the concentration achieved intravaginally with a 1% tenofovir topical gel has direct antiherpetic activity. Tenofovir inhibits the replication of HSV clinical isolates in human embryonic fibroblasts, keratinocytes, and organotypic epithelial 3D rafts, decreases HSV replication in human lymphoid and cervicovaginal tissues ex vivo, and delays HSV-induced lesions and death in topically treated HSV-infected mice. The active tenofovir metabolite inhibits HSV DNA-polymerase and HIV reverse-transcriptase. To exert dual antiviral effects, tenofovir requires topical administration to achieve a drug concentration higher than systemic levels achieved by oral treatment. These findings indicate that a single topical treatment, like tenofovir, can inhibit the transmission of HIV and its copathogens.
ISSN: 1931-3128
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Virology and Chemotherapy (Rega Institute)
Translational Cell & Tissue Research
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
2011176.pdf Published 1098KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science